The recent acquisition of Neogene Therapeutics, pioneers of T cell receptor therapies, illustrates how AstraZeneca has used business development to expand its cell-therapy capabilities beyond chimeric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback